Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/8/2025

Gastroesophageal Reflux Disease Management

Primary Treatment Approach

  • The American Gastroenterological Association recommends that patients with typical reflux symptoms should receive a 4- to 8-week trial of single-dose proton pump inhibitor therapy as first-line treatment 1, 2, 3, 4

Role of Sodium Bicarbonate in GERD Management

  • The American Gastroenterological Association recommends alginate antacids, not simple antacids like sodium bicarbonate alone, for breakthrough symptoms in patients with proven GERD 5, 2
  • Alginate-containing antacids work by forming a physical barrier and have been shown to localize the postprandial acid pocket and displace it below the diaphragm 6

Evidence-Based Treatment Algorithm

  • For new-onset typical reflux symptoms, the American Gastroenterological Association recommends starting with single-dose PPI therapy 30-60 minutes before a meal for 4-8 weeks 1, 3, 4
  • If inadequate response, increase to twice-daily PPI or switch to a more potent acid suppressive agent 2, 4
  • Consider adjunctive alginate antacids for breakthrough symptoms 5, 2

Important Caveats

  • Long-term use of sodium bicarbonate can lead to metabolic alkalosis and sodium overload, particularly problematic in patients with hypertension, heart failure, or renal disease 2

Clinical Bottom Line

  • The American Gastroenterological Association recommends that sodium bicarbonate should not replace PPI therapy as the primary treatment for GERD 1, 2, 3, 4
  • Alginate-containing antacids are preferred over simple sodium bicarbonate for breakthrough symptoms in patients already on PPI therapy 5, 6